'Treatment discontinuation' presentation slideshows

iPLEDGE The new isotretinoin registry

iPLEDGE The new isotretinoin registry. iPledge timelines. September: initial mailing to all prescribers October: Registration by pre-populated form Mid-October: Receive patient kits November: iPLEDGE goes live, doctors activate in system New pts start on iPLEDGE

1.26k views • 40 slides

Updated Abstract

Phase I/II study of oral fluoropyrimidine S-1 plus oral Leucovorin as first-line treatment for metastatic colorectal cancer. T. Yoshino 1 , W. Koizumi 2 , K. Yamaguchi 3 , Y. Miyata 4 , T. Kato 5 , Y. Toh 6 , A. Sawaki 7 , I. Hyodo 8 , T. Nishina 9 , N. Boku 1

349 views • 23 slides

HCV Infection in Marginalized Populations

HCV Infection in Marginalized Populations. Brian Conway, MD, FRCPC Vancouver Infectious Diseases Centre (VIDC). IDUs will drive the future HCV epidemic in Canada. 300,000 HCV-infected Canadians, including over 180,000 IDUs (60% of prevalent cases)

325 views • 19 slides

1 Mahon FX et al. Proc ASH 2011 ; Abstract 603. 2 Rea D et al. Proc ASH 2011;Abstract 604.

Discontinuation of Imatinib in Patients with Chronic Myeloid Leukemia Who Have Maintained Complete Molecular Response: Updated Results of the STIM 1

326 views • 15 slides

Treon SP et al. Proc ASH 2013;Abstract 757.

258 views • 10 slides

149 views • 6 slides